Dhampur Bio Organics Publishes EGM Notice for ₹305 Cr Business Transfer
Dhampur Bio Organics has published its EGM notice in Business Standard confirming the May 18, 2026 meeting for shareholder approval of the ₹305 crore Meerganj unit transfer and key leadership transitions. The notice provides comprehensive e-voting procedures and confirms electronic dispatch completion on April 24, 2026.

*this image is generated using AI for illustrative purposes only.
Dhampur Bio Organics Limited has published its Extraordinary General Meeting notice in Business Standard on April 25, 2026, confirming the EGM scheduled for Monday, May 18, 2026, at 4:00 PM IST through video conferencing. The meeting seeks shareholder approval for strategic business decisions including a major business transfer worth ₹305.00 crores and key leadership changes.
Business Transfer Proposal
The board proposes to transfer the Meerganj sugar manufacturing unit located at Bareilly, Uttar Pradesh, to Forever Global Enterprises Limited on a slump sale basis for a lump sum consideration of ₹305.00 crores. The transfer includes all assets and liabilities of the unit as a going concern, based on an independent valuer's report. The Meerganj unit contributes 15.52% to the company's total turnover, representing ₹423.24 crores out of ₹2,714.40 crores as per audited financial statements for March 31, 2025.
| Parameter: | Details |
|---|---|
| Consideration Amount: | ₹305.00 crores |
| Unit Location: | Meerganj, Bareilly, Uttar Pradesh |
| Buyer: | Forever Global Enterprises Limited |
| Transaction Type: | Slump sale basis |
| Turnover Contribution: | 15.52% (₹423.24 crores) |
The board believes the transfer will enable the company to focus on high-margin value-added businesses, become cash surplus and net debt free, and improve overall financial efficiency. The sale proceeds will primarily be used to repay and optimise company debts and maintain financial corpus for future growth opportunities.
Leadership Changes
Mr. Sandeep Kumar, currently Whole-time Director, will transition to Non-Executive Non-Independent Director effective May 5, 2026, upon completion of his tenure. He brings over 45 years of experience in operations, projects, and administration.
Mr. Nalin Kumar Gupta, currently Chief Financial Officer, has been appointed as Additional and Whole-time Director for a three-year term from May 5, 2026, to May 4, 2029. A Chartered Accountant with around 30 years of experience, he has been associated with the company for more than 25 years.
Proposed Remuneration Package
The board has proposed the following annual remuneration for Mr. Nalin Kumar Gupta as Whole-time Director:
| Component: | Amount (per annum) |
|---|---|
| Basic Salary: | ₹44,55,240 |
| House Rent Allowance: | ₹22,27,620 |
| Other Allowances: | ₹18,30,732 |
| Conveyance: | Company maintained vehicle with driver |
Additional benefits include leave encashment, leave travel allowance, performance-linked variable pay, ESOP, provident fund, and gratuity as per company policy and applicable laws. The remuneration package includes provisions for annual increases of up to 10%.
EGM and Voting Details
The company has completed electronic dispatch of the EGM notice to shareholders on Friday, April 24, 2026. The remote e-voting period commences on Thursday, May 14, 2026, at 9:00 AM and concludes on Sunday, May 17, 2026, at 5:00 PM. Shareholders whose names appear in the Register of Members as of the cut-off date of May 11, 2026, are eligible to vote.
| EGM Parameter: | Details |
|---|---|
| Meeting Date: | Monday, May 18, 2026 at 4:00 PM |
| Mode: | Video Conferencing/OAVM |
| Notice Dispatch: | April 24, 2026 |
| E-voting Period: | May 14-17, 2026 |
| Cut-off Date: | May 11, 2026 |
| Scrutinizer: | Mr. Saket Sharma, GSK & Associates |
The EGM will be conducted through VC/OAVM without physical attendance, in compliance with MCA and SEBI circulars. The business transfer requires approval through a special resolution under Section 180(1)(a) of the Companies Act, 2013, and Regulation 37A of the SEBI Listing Regulations. The leadership appointments require ordinary and special resolutions as applicable. The scrutinizer for the EGM is Mr. Saket Sharma, Partner, M/s GSK & Associates.
Historical Stock Returns for Dhampur Bio Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.75% | -8.26% | -5.06% | +54.14% | +61.46% | -32.19% |
How will the divestiture of the Meerganj unit impact Dhampur Bio Organics' sugar production capacity and market position in the competitive sugar industry?
What specific high-margin value-added businesses does Dhampur Bio Organics plan to focus on with the proceeds from this asset sale?
Could this transaction signal a broader consolidation trend in India's sugar manufacturing sector, and might other players follow similar divestiture strategies?


































